[HTML][HTML] Evaluation of biological activity of natural compounds: current trends and methods
C Barba-Ostria, SE Carrera-Pacheco… - Molecules, 2022 - mdpi.com
Natural compounds have diverse structures and are present in different forms of life.
Metabolites such as tannins, anthocyanins, and alkaloids, among others, serve as a defense …
Metabolites such as tannins, anthocyanins, and alkaloids, among others, serve as a defense …
Bio-source substances against postharvest diseases of fruits: Mechanisms, applications and perspectives
D Chen, T Chen, Y Chen, Z Zhang, B Li… - Postharvest Biology and …, 2023 - Elsevier
The safety and quality of fruit after harvest has always been an issue of people's livelihood.
Due to increasing concerns about food safety and environmental pollution caused by …
Due to increasing concerns about food safety and environmental pollution caused by …
[HTML][HTML] Sources of antifungal drugs
G Vanreppelen, J Wuyts, P Van Dijck, P Vandecruys - Journal of Fungi, 2023 - mdpi.com
Due to their eukaryotic heritage, the differences between a fungal pathogen's molecular
makeup and its human host are small. Therefore, the discovery and subsequent …
makeup and its human host are small. Therefore, the discovery and subsequent …
[HTML][HTML] Ageratum conyzoides L. and Its Secondary Metabolites in the Management of Different Fungal Pathogens
Ageratum conyzoides L.(Family—Asteraceae) is an annual aromatic invasive herb, mainly
distributed over the tropical and subtropical regions of the world. It owns a reputed history of …
distributed over the tropical and subtropical regions of the world. It owns a reputed history of …
[HTML][HTML] Non-albicans Candida Species: Immune Response, Evasion Mechanisms, and New Plant-Derived Alternative Therapies
M Gómez-Gaviria, U Ramírez-Sotelo, HM Mora-Montes - Journal of Fungi, 2022 - mdpi.com
Fungal infections caused by Candida species have become a constant threat to public
health, especially for immunocompromised patients, who are considered susceptible to this …
health, especially for immunocompromised patients, who are considered susceptible to this …
[HTML][HTML] Current landscape of methods to evaluate antimicrobial activity of natural extracts
R Gonzalez-Pastor, SE Carrera-Pacheco… - Molecules, 2023 - mdpi.com
Natural extracts have been and continue to be used to treat a wide range of medical
conditions, from infectious diseases to cancer, based on their convenience and therapeutic …
conditions, from infectious diseases to cancer, based on their convenience and therapeutic …
[HTML][HTML] Application of marine natural products against Alzheimer's disease: past, present and future
D Hu, Y Jin, X Hou, Y Zhu, D Chen, J Tai, Q Chen… - Marine Drugs, 2023 - mdpi.com
Alzheimer's disease (AD), a neurodegenerative disease, is one of the most intractable
illnesses which affects the elderly. Clinically manifested as various impairments in memory …
illnesses which affects the elderly. Clinically manifested as various impairments in memory …
[HTML][HTML] Amino acid–derived defense metabolites from plants: A potential source to facilitate novel antimicrobial development
For millennia, humanity has relied on plants for its medicines, and modern pharmacology
continues to reexamine and mine plant metabolites for novel compounds and to guide …
continues to reexamine and mine plant metabolites for novel compounds and to guide …
[HTML][HTML] Discovery of natural products with antifungal potential through combinatorial synergy
CR Augostine, SV Avery - Frontiers in Microbiology, 2022 - frontiersin.org
The growing prevalence of antifungal drug resistance coupled with the slow development of
new, acceptable drugs and fungicides has raised interest in natural products (NPs) for their …
new, acceptable drugs and fungicides has raised interest in natural products (NPs) for their …
The future of antifungal drug therapy: novel compounds and targets
C Mota Fernandes, D Dasilva… - Antimicrobial agents …, 2021 - Am Soc Microbiol
Fungal infections are a universal problem and are routinely associated with high morbidity
and mortality rates in immunocompromised patients. Existing therapies comprise five …
and mortality rates in immunocompromised patients. Existing therapies comprise five …